EST
DVAX

EA Series Trust’s Dynavax Technologies DVAX Stock Holding History

EA Series Trust’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$2.38M Buy
+183,977
New +$2.1M 0.08% 342

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

EA Series Trust's DVAX Position: Q2 2023 in Review

EA Series Trust opened a new position in Dynavax Technologies (DVAX) in Q2 2023: 183,977 shares worth $2.38M. The stake represents 0.08% of the portfolio and ranks #342 among its holdings.

215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • EA Series Trust held 183,977 shares of Dynavax Technologies worth $2.38M as of Q2 2023.
  • Dynavax Technologies was a new EA Series Trust position in Q2 2023.
  • Dynavax Technologies made up 0.08% of EA Series Trust's portfolio in Q2 2023, its #342 holding.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.